{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:26:39Z","timestamp":1771482399707,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ejmech.2019.112027","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T18:07:37Z","timestamp":1577815657000},"page":"112027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Proton pump inhibitors selectively suppress MLL rearranged leukemia cells via disrupting MLL1-WDR5 protein-protein interaction"],"prefix":"10.1016","volume":"188","author":[{"given":"Wei-Lin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1671-1582","authenticated-orcid":false,"given":"Zheng-Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Dong","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ke","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.112027_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.molcel.2010.05.011","article-title":"Multiple interactions recruit MLL1 and MLL1 fusion proteins to the HOXA9 locus in leukemogenesis","volume":"38","author":"Milne","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2019.112027_bib2","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2005.04.031","article-title":"Physical association and coordinate function of the H3K4 methyltransferase MLL1 and the H4K16 acetyltransferase MOF","volume":"121","author":"Dou","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2019.112027_bib3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.molmed.2004.08.005","article-title":"MLL: a histone methyltransferase disrupted in leukemia","volume":"10","author":"Hess","year":"2004","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2019.112027_bib4","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/sj.onc.1204174","article-title":"Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 _ 11) abnormality","volume":"20","author":"Rozovskaia","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2019.112027_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng765","article-title":"MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia","volume":"30","author":"Armstrong","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmech.2019.112027_bib6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nrc2253","article-title":"MLL translocations, histone modifications and leukaemia stem-cell development","volume":"7","author":"Krivtsov","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2019.112027_bib7","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/sj.leu.2402595","article-title":"Infant acute lymphoblastic leukemia \u2013 combined cytogenetic, immunophenotypical and molecular analysis of 77 cases","volume":"16","author":"Borkhardt","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2019.112027_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-pathol-011811-132434","article-title":"The pathogenesis of mixed-lineage leukemia","volume":"7","author":"Muntean","year":"2012","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ejmech.2019.112027_bib9","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1038\/sj.onc.1204639","article-title":"Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins","volume":"20","author":"Ayton","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2019.112027_bib10","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/leu.2013.78","article-title":"In focus: MLL-rearranged leukemia","volume":"27","author":"de Boer","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2019.112027_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-1-59745-418-6_5","article-title":"LDI-PCR: identification of known and unknown gene fusions of the human MLL gene","volume":"538","author":"Meyer","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.112027_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2141.2010.08459.x","article-title":"Mechanisms of leukemogenesis by MLL fusion proteins","volume":"152","author":"Marschalek","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejmech.2019.112027_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ccr.2009.12.034","article-title":"MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele","volume":"17","author":"Thiel","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2019.112027_bib14","doi-asserted-by":"crossref","first-page":"11367","DOI":"10.1158\/0008-5472.CAN-05-1041","article-title":"Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications","volume":"65","author":"Milne","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2019.112027_bib15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.exphem.2015.05.012","article-title":"Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond","volume":"43","author":"Chen","year":"2015","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ejmech.2019.112027_bib16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cell.2005.03.036","article-title":"WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development","volume":"121","author":"Wysocka","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2019.112027_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cell.2005.09.025","article-title":"The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis","volume":"123","author":"Yokoyama","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2019.112027_bib18","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1097-2765(02)00741-4","article-title":"MLL targets SET domain methyltransferase activity to Hox gene promoters","volume":"10","author":"Milne","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2019.112027_bib19","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1097-2765(02)00740-2","article-title":"ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation","volume":"10","author":"Nakamura","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2019.112027_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.molcel.2013.12.001","article-title":"Targeting MLL1 H3K4 methyltransferase activity in mixed-lineage leukemia","volume":"53","author":"Cao","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2019.112027_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nchembio.773","article-title":"Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia","volume":"8","author":"Grembecka","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2019.112027_bib22","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/bi00060a028","article-title":"Membrane topology and omeprazole labeling of the gastric hydrogen ion-potassium-adenosinetriphosphatase","volume":"32","author":"Besancon","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2019.112027_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/j.1875-9114.1997.tb03675.x","article-title":"Proton pump inhibitors and acid-related diseases","volume":"17","author":"Sachs","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejmech.2019.112027_bib24","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2007-09-113597","article-title":"HOXA9 is required for survival in human MLL-rearranged acute leukemias","volume":"113","author":"Faber","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2019.112027_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejmech.2016.08.036","article-title":"High-affinity small molecular blockers of mixed lineage leukemia 1 (MLL1)-WDR5 interaction inhibit MLL1 complex H3K4 methyltransferase activity","volume":"124","author":"Li","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.112027_bib26","doi-asserted-by":"crossref","first-page":"14765","DOI":"10.1073\/pnas.0503630102","article-title":"MLL associates specifically with a subset of transcriptionally active target genes","volume":"102","author":"Milne","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.112027_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molcel.2006.12.014","article-title":"Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark","volume":"25","author":"Ruthenburg","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2019.112027_bib28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1021\/ja306028q","article-title":"High-affinity small-molecule peptidomimetic inhibitors of MLL1\/WDR5 protein\u2013protein interaction","volume":"135","author":"Karatas","year":"2012","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.112027_bib29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nsmb1128","article-title":"Regulation of MLL1 H3K4 methyltransferase activity by its core components","volume":"13","author":"Dou","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.112027_bib30","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nsmb1131","article-title":"Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes","volume":"13","author":"Steward","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.112027_bib31","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1021\/jm100139b","article-title":"Analysis of the binding of mixed lineage leukemia 1 (MLL1) and histone 3 peptides to WD repeat domain 5 (WDR5) for the design of inhibitors of the MLL1-WDR5 interaction","volume":"53","author":"Karatas","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.112027_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2016.04.032","article-title":"Structure-based design and synthesis of small molecular inhibitors disturbing the interaction of MLL1-WDR5","volume":"118","author":"Li","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.112027_bib33","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1021\/acs.jmedchem.5b01630","article-title":"Structure-based optimization of a small molecule antagonist of the interaction between WD repeat-containing protein 5 (WDR5) and mixed-lineage leukemia 1 (MLL1)","volume":"59","author":"Getlik","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.112027_bib34","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11894-008-0098-4","article-title":"Pharmacology of proton pump inhibitors","volume":"10","author":"Shin","year":"2008","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.ejmech.2019.112027_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12967-015-0614-x","article-title":"Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis","volume":"13","author":"Ghebremariam","year":"2015","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.ejmech.2019.112027_bib36","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s10620-009-0951-9","article-title":"Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications","volume":"54","author":"Kedika","year":"2009","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejmech.2019.112027_bib37","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.bbrc.2006.04.170","article-title":"Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells","volume":"345","author":"Becker","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Suppl 2","key":"10.1016\/j.ejmech.2019.112027_bib38","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1097\/00004836-199506002-00025","article-title":"Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori","volume":"20","author":"Suzuki","year":"1995","journal-title":"J.\u00a0Clin. Gastroenterol."},{"key":"10.1016\/j.ejmech.2019.112027_bib39","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/00003246-200205000-00026","article-title":"Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity","volume":"30","author":"Zedtwitzliebenstein","year":"2002","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejmech.2019.112027_bib40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1365-2036.2000.014s1074.x","article-title":"A\u00a0new mechanism for anti-inflammatory actions of proton pump inhibitors--inhibitory effects on neutrophil-endothelial cell interactions","volume":"14","author":"Yoshida","year":"2000","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2019.112027_bib41","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbrc.2014.04.127","article-title":"Lansoprazole induces apoptosis of breast cancer cells through inhibition of intracellular proton extrusion","volume":"448","author":"Zhang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2019.112027_bib42","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1158\/1940-6207.CAPR-10-0033","article-title":"Novel application of proton pump inhibitor for the prevention of colitis-induced colorectal carcinogenesis beyond acid suppression","volume":"3","author":"Kim","year":"2010","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.ejmech.2019.112027_bib43","first-page":"170","article-title":"Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats","volume":"40","author":"Patlolla","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2019.112027_bib44","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1158\/0008-5472.CAN-06-4095","article-title":"Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species","volume":"67","author":"De","year":"2007","journal-title":"Cancer Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419311857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419311857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:05:59Z","timestamp":1759327559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419311857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":44,"alternative-id":["S0223523419311857"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.112027","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton pump inhibitors selectively suppress MLL rearranged leukemia cells via disrupting MLL1-WDR5 protein-protein interaction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.112027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112027"}}